Corcept Therapeutics Incorporated · NASDAQ:CORT
BlackRock, Inc. reported a 12.70% stake in Corcept Therapeutics Incorporated (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 23, 2025
BlackRock, Inc. reported a 12.70% stake in Corcept Therapeutics Incorporated, 13,349,143 shares, as a passive investor on Mar 31, 2025. Filed Apr 23, 2025 (Schedule 13G/A).
- Stake
- 12.70%
- Shares
- 13,349,143
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 12.70% | 13,349,143 |
Source
Related
- Corcept Therapeutics Incorporated
- BlackRock, Inc.
- Corcept Therapeutics Incorporated shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026